Pre‐existing psoriasis and immune‐related adverse events following immunotherapy for lung cancer

Key Points

• This research investigates how pre-existing psoriasis affects immune-related adverse events in lung cancer patients receiving immunotherapy.
• Data collection from lung cancer patients receiving immunotherapy
• Analysis of the prevalence of psoriasis among participants
• Assessment of immune-related adverse events
• Identified a correlation between pre-existing psoriasis and increased immune-related adverse events
• Provided insights into potential management strategies for affected patients

Abstract